Meta, formerly known as Facebook, has announced it will change its stock ticker from "FB" to reflect its new name change. Read More...
Motley Fool
Why Veru Stock Surged Today
Shares of Veru (NASDAQ: VERU) surged 16.8% on Tuesday, after the biopharmaceutical company submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for its novel coronavirus oral drug candidate, sabizabulin. Sabizabulin is a once-daily antiviral and anti-inflammatory treatment for hospitalized patients with moderate to severe COVID-19, who are at high risk of acute respiratory distress syndrome. “COVID-19 new cases and hospitalizations are on the rise again with a summer and fall-winter peaks expected,” Veru CEO Mitchell Steiner said in a press release.
Add Comment